Excellence in Oncology Care (EIOC) shared a post on LinkedIn:
“We are honored to welcome Dr. Filippo Pietrantonio, Head of the Gastrointestinal Oncology Unit at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, to the GI Cancer Molecular Tumor Board at EIOC 2025.
A leading expert in gastrointestinal oncology, Dr. Pietrantonio directs a research team pioneering novel therapies for colorectal and gastric cancers, while advancing translational research on resistance mechanisms to targeted therapies and immunotherapy. As Principal Investigator of 100+ clinical trials and author of 350+ peer-reviewed publications, his contributions continue to shape the future of GI cancer care worldwide.
Join us virtually on Day 3 of EIOC 2025 to hear his expertise.”
More from Excellence in Oncology Care on OncoDaily.